Provided by Tiger Trade Technology Pte. Ltd.

LONGBIO-B

142.800
+0.9000.63%
Volume:12.55K
Turnover:1.78M
Market Cap:10.59B
PE:-52.25
High:143.600
Open:141.600
Low:141.400
Close:141.900
52wk High:158.000
52wk Low:116.100
Shares:74.19M
HK Float Shares:72.93M
Volume Ratio:0.18
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-2.733
ROE:--
ROA:-54.56%
PB:65.13
PE(LYR):-52.25
PS:- -

Loading ...

LongBio Pharma’s LP-003 Hits Primary Goals in China Phase III Seasonal Allergic Rhinitis Study

Bulletin Express
·
3 hours ago

LONGBIO-B's Phase III Trial for Seasonal Allergic Rhinitis Drug LP-003 Meets Primary Endpoint

Stock News
·
3 hours ago

Longbio Pharma (Suzhou) Co - Phase Iii Trial of Lp-3 for Seasonal Allergic Rhinitis Meets Primary Endpoints

THOMSON REUTERS
·
3 hours ago

LongBio Pharma Announces 2025 AGM; Shareholders to Vote on Profit Distribution, Auditor Re-appointment and Dual Mandates

Bulletin Express
·
Jun 09

Can LONGBIO-B Maintain Its Lofty Valuation Ahead of a Potential Stock Connect Inclusion?

Stock News
·
Jun 09

Movement Alert|Tiachen Bio-B Rises 6.37% in Regular Trading, Sustaining IPO Oversubscription Momentum on Second Trading Day

Market Focus
·
Jun 09

Regulator Seeks Clarification from Weizhao Semiconductor on Pricing Disparities Ahead of Planned Hong Kong IPO

Stock News
·
Jun 05

LONGBIO-B Commences Trading on HKEX with Shares Surging Over 50% at Opening

Deep News
·
Jun 05

IPO Spotlight: Longbio-B Soars on Debut as Investor Demand Soars

Deep News
·
Jun 05

Hong Kong Market Closes Lower, Hang Seng Drops 1.15% Below 25,000; Semiconductors Retreat Sharply; Three New Listings Show Divergent Performance

Stock News
·
Jun 05

Hong Kong Stocks End Week in Red; Three Firms Make Market Debut

MT Newswires Live
·
Jun 05

Stock Track | LONGBIO-B Soars 54.80% Intraday on Blockbuster IPO Debut with Massive Oversubscription

Stock Track
·
Jun 05

Movement Alert|Tianchen Bio-B Rises 51.05% in Regular Trading, Surging on IPO Debut with Over 4762x Oversubscription

Market Focus
·
Jun 05

New Listing Debut | LONGBIO-B (01779) Starts Trading with 50.22% Premium, Core Product LP-003 in Eight Chinese Clinical Trials

Stock News
·
Jun 05

LongBio Pharma Raises HK$1.3 Billion in Hong Kong IPO Ahead of Debut

MT Newswires Live
·
Jun 05

Longbio-B IPO Sees Massive Oversubscription, Raises Approximately HK$1.255 Billion

Stock News
·
Jun 04

New Stock Pre-Market Surge: LONGBIO-B (01779) Soars Over 135%, Generating HK$6,487 Per Board Lot

Stock News
·
Jun 04

HK Grey Market | LongBio Jumps 138%; Lung Fung Jumps 22%; Dajin Heavy Drops 5%;

Tiger Newspress
·
Jun 04

LongBio Pharma Releases Updated Board Composition and Committee Assignments

Bulletin Express
·
Jun 04

LongBio Pharma Publishes Detailed Audit Committee Charter to Bolster Governance Framework

Bulletin Express
·
Jun 04